# A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

> **NCT05999942** · PHASE1 · COMPLETED · sponsor: **Insmed Incorporated** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Liposomal Amikacin for Inhalation

## Key facts

- **NCT ID:** NCT05999942
- **Lead sponsor:** Insmed Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06-02
- **Primary completion:** 2004-06-29
- **Final completion:** 2004-06-29
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05999942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05999942, "A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05999942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*